Reuters India Business

Gambia police link child deaths to cough syrup imported by pharma firm

(This Oct. 11 story has been corrected to remove incorrect reference to pharmaceutical company based in United States in the first paragraph, and Atlanta in 4th & 5th paragraphs) BANJUL (Reuters) – The deaths of 69 children from acute kidney injury in Gambia is linked to four cough syrups made in India and imported into …

Gambia police link child deaths to cough syrup imported by pharma firm Read More »

Senegal hones its home-grown rice to cut dependence on Asian imports

By Ngouda Dione and Elodie Toto DAKAR/DAGANA, Senegal (Reuters) – Senegalese cook Amy Gueye always tries to use imported rice at her family-run restaurant in Dakar, knowing that customers prefer the taste to home-grown varieties when they buy her spicy rice-based fish and chicken dishes.     Senegal’s rice production has soared in recent years as it …

Senegal hones its home-grown rice to cut dependence on Asian imports Read More »

India’s SEBI clears govt proposal to turn Vodafone Idea dues into equity – sources

By Nikunj Rajesh Ohri NEW DELHI (Reuters) – India’s capital market regulator approved the government’s proposal to convert dues of over $1.92 billion by telecom operator Vodafone Idea to equity, two senior government officials said on Thursday. Last year, India had approved a rescue package for debt-strapped telecom companies that allowed them to convert interest …

India’s SEBI clears govt proposal to turn Vodafone Idea dues into equity – sources Read More »

Indian equities to stand out, rupee a risk-Avendus Capital’s Holland

By Savio Shetty and Swati Bhat MUMBAI (Reuters) – Indian equities are likely to stand out in the months ahead, though they may not decouple from other markets globally, but the rupee’s steep fall could limit foreign investors’ gains, the top executive at Avendus Capital told Trading India on Thursday. While India’s NSE share index …

Indian equities to stand out, rupee a risk-Avendus Capital’s Holland Read More »

Paracetamol maker Granules India quarterly profit jumps 80%

BENGALURU (Reuters) – Pharmaceutical company Granules India Ltd reported an 80% surge in quarterly profit on Thursday, boosted by higher sales of painkiller drug Paracetamol. Consolidated profit for the company, which also makes anti-inflammatory drug Ibuprofen, came in at 1.45 billion Indian rupees ($17.43 million) for the three months ended Sept. 30, compared with 806.8 …

Paracetamol maker Granules India quarterly profit jumps 80% Read More »

India’s Asian Paints misses profit estimates on extended monsoon, high costs

BENGALURU (Reuters) – India’s top paint maker Asian Paints Ltd reported a lower-than-expected rise in second-quarter profit on Thursday, as price hikes were not enough to offset an extended monsoon and higher input costs. The company’s consolidated net profit rose 31.3% year-over-year to 7.83 billion rupees ($94.38 million) in the quarter, but missed analysts’ expectations …

India’s Asian Paints misses profit estimates on extended monsoon, high costs Read More »

India’s home sales, prices to rise, defying rate hikes – Puravankara CEO

By Nivedita Bhattacharjee BENGALURU (Reuters) – Puravankara Ltd, one of India’s top property developers, expects both prices and new home sales to rise in the near future, defying rising interest rates, partly due to a recovering job market and strong demand from older millennials, a top company executive said. The Reserve Bank of India has …

India’s home sales, prices to rise, defying rate hikes – Puravankara CEO Read More »

Pernod Ricard confident over FY as Q1 sales beat expectations

By Dominique Vidalon PARIS (Reuters) -Pernod Ricard said on Thursday it was confident sales growth would remain dynamic through its 2023 fiscal year after it delivered forecast-beating sales in the first quarter helped by price increases as consumers trade up to its premium spirits. Pernod, the world’s second-biggest spirits group behind Diageo, successfully raised prices …

Pernod Ricard confident over FY as Q1 sales beat expectations Read More »

Close Bitnami banner
Bitnami